Stefania Merighi focuses on Adenosine receptor, Adenosine, Receptor, Adenosine A3 receptor and Purinergic signalling. Her Adenosine receptor study combines topics in areas such as Cell growth and Binding site. She combines subjects such as Cancer cell and Cancer research with her study of Adenosine.
Her work carried out in the field of Cancer research brings together such families of science as Protein kinase B and Cell migration. Her Receptor research incorporates themes from Signal transduction, Pharmacology and Downregulation and upregulation. Her studies in Purinergic signalling integrate themes in fields like Inflammation, Endocrinology and CGS-21680.
Stefania Merighi mainly focuses on Adenosine receptor, Receptor, Adenosine, Pharmacology and Stereochemistry. The concepts of her Adenosine receptor study are interwoven with issues in Endocrinology and Cancer research. Her Receptor study combines topics from a wide range of disciplines, such as Signal transduction, Stimulation and Binding site.
Her Adenosine research includes elements of Inflammation, Adenosine A1 receptor, Vascular endothelial growth factor, Molecular biology and Adenosine A2B receptor. Her studies in Pharmacology integrate themes in fields like Allosteric modulator, Allosteric regulation, Chronic pain and Nucleoside. Her Stereochemistry research includes elements of Antagonist and Chemical synthesis.
Stefania Merighi mostly deals with Adenosine receptor, Adenosine, Receptor, Pharmacology and Inflammation. Stefania Merighi specializes in Adenosine receptor, namely Purinergic signalling. Her Adenosine study integrates concerns from other disciplines, such as Adenosinergic, Autacoid and Nucleoside.
Her research in Receptor intersects with topics in Cell signaling, Signal transduction, Neurodegeneration, Proinflammatory cytokine and Neuroscience. Stefania Merighi has included themes like Allosteric modulator, Allosteric regulation and Purinergic P1 Receptor Antagonists in her Pharmacology study. Stefania Merighi interconnects Tumor necrosis factor alpha, Interleukin and Adenosine A3 receptor in the investigation of issues within Inflammation.
The scientist’s investigation covers issues in Receptor, Adenosine receptor, Adenosine, Pharmacology and Inflammation. Her work carried out in the field of Receptor brings together such families of science as Neuroinflammation, Signal transduction, Cell biology, Endogeny and Proinflammatory cytokine. Stefania Merighi combines subjects such as Cell signaling, Dopamine and Stimulation with her study of Adenosine receptor.
Stefania Merighi has researched Adenosine in several fields, including Autacoid, Neuroscience and Purinergic P1 Receptor Antagonists. Her Pharmacology research is multidisciplinary, incorporating perspectives in Cancer cell, Adenylyl cyclase, Immune system and Predictive marker. Stefania Merighi usually deals with Inflammation and limits it to topics linked to Adenosine A3 receptor and Purinergic signalling, Adenosine triphosphate and Fibrosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A glance at adenosine receptors: novel target for antitumor therapy
Stefania Merighi;Prisco Mirandola;Katia Varani;Stefania Gessi.
Pharmacology & Therapeutics (2003)
The A3 adenosine receptor: an enigmatic player in cell biology.
Stefania Gessi;Stefania Merighi;Katia Varani;Edward Leung.
Pharmacology & Therapeutics (2008)
Adenosine Receptors and Cancer
Stefania Gessi;Stefania Merighi;Valeria Sacchetto;Carolina Simioni.
Biochimica et Biophysica Acta (2011)
Pharmacology of Adenosine Receptors: The State of the Art
Pier Andrea Borea;Stefania Gessi;Stefania Merighi;Fabrizio Vincenzi.
Physiological Reviews (2018)
The A3 Adenosine Receptor: History and Perspectives
Pier Andrea Borea;Katia Varani;Fabrizio Vincenzi;Pier Giovanni Baraldi.
Pharmacological Reviews (2015)
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
Pier Andrea Borea;Stefania Gessi;Stefania Merighi;Katia Varani.
Trends in Pharmacological Sciences (2016)
A2A adenosine receptors in human peripheral blood cells
S Gessi;K Varani;S Merighi;E Ongini.
British Journal of Pharmacology (2000)
A3 Adenosine Receptor Ligands: History and Perspectives
Pier Giovanni Baraldi;Barbara Cacciari;Romeo Romagnoli;Stefania Merighi.
Medicinal Research Reviews (2000)
[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
Katia Varani;Stefania Merighi;Stefania Gessi;Karl-Norbert Klotz.
Molecular Pharmacology (2000)
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells.
Stefania Merighi;Prisco Mirandola;Prisco Mirandola;Daniela Milani;Katia Varani.
Journal of Investigative Dermatology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: